-
Product Insights
Bluefield Preserve Solar Energy Center
Bluefield Preserve Solar Energy Center is a solar PV project located in Florida, United States. The project is owned and developed by Florida Power & Light Co. The project came online in 2023. Empower your strategies with our Bluefield Preserve Solar Energy Center report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
FPL Babcock Preserve Solar Energy Center
FPL Babcock Preserve Solar Energy Center is a solar PV project located in Florida, United States. The project is owned and developed by Florida Power & Light Co. The project came online in 2020. Empower your strategies with our FPL Babcock Preserve Solar Energy Center report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
FPL Northern Preserve Solar Energy Center
FPL Northern Preserve Solar Energy Center is a solar PV project located in Florida, United States. The project is owned and developed by Florida Power & Light Co. The project came online in 2020. Empower your strategies with our FPL Northern Preserve Solar Energy Center report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
NewLikelihood of Approval Analysis for Non-infectious Uveitis
Overview How likely is it that the drugs in Non-infectious Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-infectious Uveitis Overview Non-infectious uveitis (NIU) is a group of disorders characterized...
-
Product Insights
NewLikelihood of Approval Analysis for Arthritis Pain
Overview How likely is it that the drugs in Arthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arthritis Pain Overview Arthritis pain stems from inflammation in joints, causing discomfort,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Levosimendan in Diastolic Heart Failure (HFpEF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levosimendan in Diastolic Heart Failure (HFpEF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levosimendan in Diastolic Heart Failure (HFpEF) Drug Details: Levosimendan (Simdax,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levosimendan in Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levosimendan in Pulmonary Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levosimendan in Pulmonary Hypertension Drug Details: Levosimendan (Simdax, Zimino) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Empagliflozin in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Empagliflozin in Pulmonary Arterial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Empagliflozin in Pulmonary Arterial Hypertension Drug Details: Empagliflozin (Jardiance, BI...